KMT2A and acute myeloid leukemia: To uncover the key signaling pathways and gene-expression alterations resulting from suppression of the catalytic activity of UBE2N in AML cells, we performed RNA-Seq on Ube2nC87S and Ube2nWT MLL-AF9 AML cells.